A CFTR corrector (lumacaftor) and a CFTR potentiator (ivacaftor) for treatment of patients with cystic fibrosis who have a phe508del CFTR mutation: a phase 2 randomised controlled trial - Concepedia

Concepedia

Publication | Closed Access

A CFTR corrector (lumacaftor) and a CFTR potentiator (ivacaftor) for treatment of patients with cystic fibrosis who have a phe508del CFTR mutation: a phase 2 randomised controlled trial

436

Citations

17

References

2014

Year

Michael Boyle, Scott C. Bell, Michael W. Konstan, Susanna A. McColley, Steven M. Rowe, Ernst Rietschel, Xiaohong Huang, David Waltz, Naimish Patel, David M. Rodman

The Lancet Respiratory Medicine

PathologyCftr CorrectorPulmonary FibrosisMedicinePhe508del Cftr MutationMolecular Medicine

References

	Year	Citations

Page 1